We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Abnormal proliferation and differentiation of osteoblasts from girls with adolescent idiopathic scoliosis to melatonin.
- Authors
Gene Chi-wai Man; Wei-jun Wang, William; Benson Hiu-yan Yeung; Kwong-man Lee, Simon; Kin- ah Ng, Bobby; Wing-yin Hung; Wong, Jack Ho; Tzi-bun Ng; Yong Qiu; Chun-yiu Cheng, Jack
- Abstract
Melatonin deficiency has been postulated as an etiologic factors in adolescent idiopathic scoliosis (AIS). In previous studies, melatonin was shown to regulate skeletal growth and bone formation in both humans and rats. Although it remains controversial whether there are differences in serum melatonin level between AIS and control subjects, melatonin signaling pathway dysfunction in osteoblasts has been reported in patients with AIS. Recently, our group found that melatonin receptor 1B (MT2) gene polymorphism was associated with the occurrence of AIS. Hence, the present study investigated the effect of melatonin on AIS osteoblasts. In vitro assays were performed with osteoblasts isolated from 17 severe AIS girls and nine control subjects. The osteoblasts were exposed to different concentrations of melatonin for 3 days. The effects of melatonin on cell proliferation (as evidenced by MTT assay) and differentiation (demonstrated by alkaline phosphatase activity) were determined. In the control group, melatonin significantly stimulated osteoblasts to proliferate and differentiate. However, in the AIS group, the stimulatory effects of melatonin were not discernible. Importantly, this finding demonstrated that there is a significant difference between AIS and control osteoblasts in functional response toward melatonin. Melatonin-stimulated proliferation of control osteoblasts was inhibited by the MT2 antagonist, 4-phenyl-2-propionamidotetraline, as well as by luzindole, a nonselective melatonin receptor antagonist, suggesting that MT2 is associated with the proliferative action of melatonin. The lack of response in AIS osteoblasts might be because of dysfunction of the melatonin signaling pathway, which may contribute to the low bone mineral density and abnormal skeletal growth observed in patients with AIS.
- Subjects
SCOLIOSIS; MELATONIN; DISEASES in women; BONE growth; MICROBIOLOGICAL assay
- Publication
Journal of Pineal Research, 2010, Vol 49, Issue 1, p69
- ISSN
0742-3098
- Publication type
Article
- DOI
10.1111/j.1600-079X.2010.00768.x